| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 421-427, Copyright © 1994 by Endocrine Society
ARTICLES |
DR Repaske and JE Browning
Division of Endocrinology, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039.
The molecular basis of autosomal dominant neurohypophyseal diabetes insipidus, a hereditary deficiency of vasopressin, was determined by nucleotide sequence analysis of the arginine vasopressin-neurophysin-II gene. A C-->T mutation at nucleotide 1761 was detected in one allele of this gene in each affected individual in three generations of one family. This mutant gene encodes a normal arginine vasopressin peptide, but predicts a substitution of leucine for proline at amino acid 24 of neurophysin-II, the arginine vasopressin carrier protein. This mutation was not detected 50 control individuals, thus demonstrating that it is not a common silent genetic polymorphism. The disease arose in the second generation of the studied family, and the chromosome 20 carrying this new mutation was identified by polymorphic CA microsatellite haplotype analysis. The first affected individual inherited this chromosome segment from her mother, who had neither the disease nor this mutation in her somatic cell DNA. Third generation individuals who subsequently inherited this mutation were affected. These data demonstrate that this amino acid substitution in neurophysin-II causes the disease. Two possibilities to explain the mechanism by which clinical deficiency of arginine vasopressin develops even in the presence of one normal arginine vasopressin-neurophysin-II allele are discussed.
This article has been cited by other articles:
![]() |
C. P. Mahoney, E. Weinberger, C. Bryant, M. Ito, J. L. Jameson, and M. Ito Effects of Aging on Vasopressin Production in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus Due to the {Delta}E47 Neurophysin Mutation J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 870 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Abbes, B. Bruggeman, E. L.T. van den Akker, M. R. de Groot, A. A.M. Franken, V. R. Drexhage, and H. Engel Identification of Two Distinct Mutations at the Same Nucleotide Position, Concomitantly with a Novel Polymorphism in the Vasopressin-Neurophysin II Gene (AVP-NP II) in Two Dutch Families with Familial Neurohypophyseal Diabetes Insipidus Clin. Chem., October 1, 2000; 46(10): 1699 - 1702. [Full Text] [PDF] |
||||
![]() |
B. Calvo, J. R. Bilbao, A. Rodríguez, M. D. Rodríguez-Arnao, and L. Castaño Molecular Analysis in Familial Neurohypophyseal Diabetes Insipidus: Early Diagnosis of an Asymptomatic Carrier J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3351 - 3354. [Abstract] [Full Text] |
||||
![]() |
C. Siggaard, S. Rittig, T. J. Corydon, P. H. Andreasen, T. G. Jensen, B. S. Andresen, G. L. Robertson, N. Gregersen, L. Bolund, and E. B. Pedersen Clinical and Molecular Evidence of Abnormal Processing and Trafficking of the Vasopressin Preprohormone in a Large Kindred with Familial Neurohypophyseal Diabetes Insipidus due to A Signal Peptide Mutation J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2933 - 2941. [Abstract] [Full Text] |
||||
![]() |
M. Ito, R. N. Yu, J. L. Jameson, and M. Ito Mutant Vasopressin Precursors That Cause Autosomal Dominant Neurohypophyseal Diabetes Insipidus Retain Dimerization and Impair the Secretion of Wild-type Proteins J. Biol. Chem., March 26, 1999; 274(13): 9029 - 9037. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Grant, A. Ahmadi, C. M. Hosley, and J. A. Majzoub Two Novel Mutations of the Vasopressin Gene Associated with Familial Diabetes Insipidus and Identification of an Asymptomatic Carrier Infant J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3958 - 3964. [Abstract] [Full Text] |
||||
![]() |
B. Calvo, J. R. Bilbao, I. Urrutia, J. Eizaguirre, S. Gaztambide, and L. Castaño Identification of a Novel Nonsense Mutation and a Missense Substitution in the Vasopressin-Neurophysin II Gene in Two Spanish Kindreds with Familial Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 995 - 997. [Abstract] [Full Text] |
||||
![]() |
P. C. Gagliardi, S. Bernasconi, and D. R. Repaske Autosomal Dominant Neurohypophyseal Diabetes Insipidus Associated with a Missense Mutation Encoding Gly23->Val in Neurophysin II J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3643 - 3646. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Repaske, R. Medlej, E. K. Gultekin, M. R. S. Krishnamani, G. Halaby, J. W. Findling, and J. A. Phillips III Heterogeneity in Clinical Manifestation of Autosomal Dominant Neurohypophyseal Diabetes Insipidus Caused by a Mutation Encoding Ala-1->Val in the Signal Peptide of the Arginine Vasopressin/Neurophysin II/Copeptin Precursor J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 51 - 56. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |